In melanoma cells in vivo, Wnt/β-catenin signaling prevents the priming of antitumor responses by disrupting the recruitment of dendritic cells expressing basic leucine zipper transcriptional factor ATF-like 3 (BATF3) [48]. The gene discussed is BATF3; the disease is melanoma.